PASQUINI, Silvia
PASQUINI, Silvia
Dipartimento di Scienze chimiche, farmaceutiche ed agrarie
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators
file con accesso da definire2023 Oliva, Paola; Suresh, R Rama; Pasquini, Silvia; Salmaso, Veronica; Will, Edward J; Tosh, Dilip K; Gao, Zhan-Guo; Liu, Naili; Gavrilova, Oksana; Vincenzi, Fabrizio; Varani, Katia; Jacobson, Kenneth A
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives
2022 Catarzi, D.; Varano, F.; Vigiani, E.; Calenda, S.; Melani, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Mennini, N.; Nerli, G.; Dal Ben, D.; Volpini, R.; Colotta, V.
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
2020 Vincenzi, F.; Pasquini, S.; Battistello, E.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease
2021 Gessi, Stefania; Poloni, Tino Emanuele; Negro, Giulia; Varani, Katia; Pasquini, Silvia; Vincenzi, Fabrizio; Borea, Pier Andrea; Merighi, Stefania
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?
2022 Merighi, Stefania; Nigro, Manuela; Travagli, Alessia; Pasquini, Silvia; Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Gessi, Stefania
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma
2021 Vincenzi, F.; Rotondo, J. C.; Pasquini, S.; Di Virgilio, F.; Varani, K.; Tognon, M.
Adenosine and inflammation: Here, there and everywhere
2021 Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K.
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields
file con accesso da definire2017 Varani, Katia; Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Setti, Stefania; Cadossi, Matteo; Borea, Pier Andrea; Cadossi, Ruggero
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
2022 Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F.
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes
2020 Pasquini, S.; Vincenzi, F.; Casetta, I.; Laudisi, M.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists
2019 Catarzi, D.; Varano, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Dal Ben, D.; Volpini, R.; Colotta, V.
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?
2021 Merighi, Stefania; Poloni, Tino Emanuele; Pelloni, Lucia; Pasquini, Silvia; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors
2023 Gianferrara, Teresa; Pavan, Matteo; Bassani, Davide; Vincenzi, Fabrizio; Pasquini, Silvia; Bolcato, Giovanni; Varani, Katia; Spalluto, Giampiero; Federico, Stephanie; Moro, Stefano
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
file con accesso da definire2024 Bedini, Annalida; Elisi, Gian Marco; Fanini, Fabiola; Retini, Michele; Scalvini, Laura; Pasquini, Silvia; Contri, Chiara; Varani, Katia; Spadoni, Gilberto; Mor, Marco; Vincenzi, Fabrizio; Rivara, Silvia
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target?
2023 Merighi, Stefania; Travagli, Alessia; Nigro, Manuela; Pasquini, Silvia; Cappello, Martina; Contri, Chiara; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study
file con accesso da definire2024 Porto, Francesca; Speltri, Giorgia; Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Martini, Petra; Boschi, Alessandra; Uccelli, Licia; Varani, Katia; DI DOMENICO, Giovanni; Vincenzi, Fabrizio
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists
file con accesso da definire2012 Pasquini, S; Mugnaini, C; Ligresti, A; Tafi, A; Brogi, S; Falciani, C; Pedani, V; Pesco, N; Guida, F; Luongo, L; Varani, Katia; Borea, Pa; Maione, S; Di Marzo, V; Corelli, F.
Development of novel pyridazinone-based adenosine receptor ligands
2018 Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Varani, Katia; Vincenzi, Fabrizio; Pasquini, Silvia; Dal Ben, Diego; Colotta, Vittoria
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
2023 Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania
Effect of Low-Frequency, Low-Energy Pulsed Electromagnetic Fields in Neuronal and Microglial Cells Injured with Amyloid-Beta
file con accesso da definire2024 Merighi, Stefania; Nigro, Manuela; Travagli, Alessia; Fernandez, Mercedes; Vincenzi, Fabrizio; Varani, Katia; Pasquini, Silvia; Borea, Pier Andrea; Salati, Simona; Cadossi, Ruggero; Gessi, Stefania
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators | 2023 | Oliva, Paola; Suresh, R Rama; Pasquini, Silvia; Salmaso, Veronica; Will, Edward J; Tosh, Dilip K;... Gao, Zhan-Guo; Liu, Naili; Gavrilova, Oksana; Vincenzi, Fabrizio; Varani, Katia; Jacobson, Kenneth A | file con accesso da definire |
| 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives | 2022 | Catarzi, D.; Varano, F.; Vigiani, E.; Calenda, S.; Melani, F.; Varani, K.; Vincenzi, F.; Pasquini..., S.; Mennini, N.; Nerli, G.; Dal Ben, D.; Volpini, R.; Colotta, V. | |
| A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? | 2020 | Vincenzi, F.; Pasquini, S.; Battistello, E.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K. | |
| A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease | 2021 | Gessi, Stefania; Poloni, Tino Emanuele; Negro, Giulia; Varani, Katia; Pasquini, Silvia; Vincenzi,... Fabrizio; Borea, Pier Andrea; Merighi, Stefania | |
| A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? | 2022 | Merighi, Stefania; Nigro, Manuela; Travagli, Alessia; Pasquini, Silvia; Borea, Pier Andrea; Varan...i, Katia; Vincenzi, Fabrizio; Gessi, Stefania | |
| A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma | 2021 | Vincenzi, F.; Rotondo, J. C.; Pasquini, S.; Di Virgilio, F.; Varani, K.; Tognon, M. | |
| Adenosine and inflammation: Here, there and everywhere | 2021 | Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K. | |
| Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields | 2017 | Varani, Katia; Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, ...Stefania; Setti, Stefania; Cadossi, Matteo; Borea, Pier Andrea; Cadossi, Ruggero | file con accesso da definire |
| Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets | 2022 | Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F. | |
| Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes | 2020 | Pasquini, S.; Vincenzi, F.; Casetta, I.; Laudisi, M.; Merighi, S.; Gessi, S.; Borea, P. A.; Varan...i, K. | |
| Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists | 2019 | Catarzi, D.; Varano, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Dal Ben, D.; Volpini, R.; Colott...a, V. | |
| An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? | 2021 | Merighi, Stefania; Poloni, Tino Emanuele; Pelloni, Lucia; Pasquini, Silvia; Varani, Katia; Vincen...zi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania | |
| Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors | 2023 | Gianferrara, Teresa; Pavan, Matteo; Bassani, Davide; Vincenzi, Fabrizio; Pasquini, Silvia; Bolcat...o, Giovanni; Varani, Katia; Spalluto, Giampiero; Federico, Stephanie; Moro, Stefano | |
| Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence | 2024 | Bedini, Annalida; Elisi, Gian Marco; Fanini, Fabiola; Retini, Michele; Scalvini, Laura; Pasquini,... Silvia; Contri, Chiara; Varani, Katia; Spadoni, Gilberto; Mor, Marco; Vincenzi, Fabrizio; Rivara, Silvia | file con accesso da definire |
| Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? | 2023 | Merighi, Stefania; Travagli, Alessia; Nigro, Manuela; Pasquini, Silvia; Cappello, Martina; Contri..., Chiara; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania | |
| Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study | 2024 | Porto, Francesca; Speltri, Giorgia; Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Martini,... Petra; Boschi, Alessandra; Uccelli, Licia; Varani, Katia; DI DOMENICO, Giovanni; Vincenzi, Fabrizio | file con accesso da definire |
| Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists | 2012 | Pasquini, S; Mugnaini, C; Ligresti, A; Tafi, A; Brogi, S; Falciani, C; Pedani, V; Pesco, N; Guida..., F; Luongo, L; Varani, Katia; Borea, Pa; Maione, S; Di Marzo, V; Corelli, F. | file con accesso da definire |
| Development of novel pyridazinone-based adenosine receptor ligands | 2018 | Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Varani, Katia; Vincenzi, Fabrizio; Pasquini, S...ilvia; Dal Ben, Diego; Colotta, Vittoria | |
| Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions | 2023 | Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; ...Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania | |
| Effect of Low-Frequency, Low-Energy Pulsed Electromagnetic Fields in Neuronal and Microglial Cells Injured with Amyloid-Beta | 2024 | Merighi, Stefania; Nigro, Manuela; Travagli, Alessia; Fernandez, Mercedes; Vincenzi, Fabrizio; Va...rani, Katia; Pasquini, Silvia; Borea, Pier Andrea; Salati, Simona; Cadossi, Ruggero; Gessi, Stefania | file con accesso da definire |